Dp Vii Associates Lp - Net Worth and Insider Trading
Dp Vii Associates Lp Net Worth
The estimated net worth of Dp Vii Associates Lp is at least $436,559 dollars as of 2024-04-26. Dp Vii Associates Lp is the 10% Owner of Zogenix Inc and owns about 13,819 shares of Zogenix Inc (ZGNX) stock worth over $368,691. Dp Vii Associates Lp is the 10% Owner of Esperion Therapeutics Inc and owns about 35,253 shares of Esperion Therapeutics Inc (ESPR) stock worth over $66,804. Dp Vii Associates Lp is also the 10% Owner of Clovis Oncology Inc and owns about 44,034 shares of Clovis Oncology Inc (CLVSQ) stock worth over $661. Besides these, Dp Vii Associates Lp also holds Evoke Pharma Inc (EVOK) , Orexigen Therapeutics Inc (OREXQ) . Details can be seen in Dp Vii Associates Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dp Vii Associates Lp has not made any transactions after 2016-05-26 and currently still holds the listed stock(s).
Transaction Summary of Dp Vii Associates Lp
Dp Vii Associates Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dp Vii Associates Lp owns 11 companies in total, including Regado Biosciences Inc (RGDO) , Obalon Therapeutics Inc (OBLN) , and Evoke Pharma Inc (EVOK) among others .
Click here to see the complete history of Dp Vii Associates Lp’s form 4 insider trades.
Insider Ownership Summary of Dp Vii Associates Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RGDO | Regado Biosciences Inc | 2016-11-01 | 10 percent owner |
| OBLN | Obalon Therapeutics Inc | 2016-10-12 | 10 percent owner |
| EVOK | Evoke Pharma Inc | 2016-05-26 | 10 percent owner |
| EVFM | Evofem Biosciences Inc | 2014-11-19 | 10 percent owner |
| AKAOQ | Achaogen Inc | 2014-03-17 | 10 percent owner |
| TNDM | Tandem Diabetes Care Inc | 2013-11-13 | 10 percent owner |
| ESPR | Esperion Therapeutics Inc | 2013-07-01 | 10 percent owner |
| CLVSQ | Clovis Oncology Inc | 2013-06-04 | 10 percent owner |
| OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 10 percent owner |
| ZGNX | Zogenix Inc | 2011-09-16 | 10 percent owner |
| RSLS | Reshape Lifesciences Inc | 2016-10-05 | 10 percent owner |
Dp Vii Associates Lp Latest Holdings Summary
Dp Vii Associates Lp currently owns a total of 5 stocks. Among these stocks, Dp Vii Associates Lp owns 13,819 shares of Zogenix Inc (ZGNX) as of November 29, 2010, with a value of $368,691 and a weighting of 84.45%. Dp Vii Associates Lp owns 35,253 shares of Esperion Therapeutics Inc (ESPR) as of July 1, 2013, with a value of $66,804 and a weighting of 15.3%. Dp Vii Associates Lp also owns 44,034 shares of Clovis Oncology Inc (CLVSQ) as of June 4, 2013, with a value of $661 and a weighting of 0.15%. The other 2 stocks Evoke Pharma Inc (EVOK) , Orexigen Therapeutics Inc (OREXQ) have a combined weighting of 0.09% among all his current holdings.
Latest Holdings of Dp Vii Associates Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZGNX | Zogenix Inc | 2010-11-29 | 13,819 | 26.68 | 368,691 |
| ESPR | Esperion Therapeutics Inc | 2013-07-01 | 35,253 | 1.90 | 66,804 |
| CLVSQ | Clovis Oncology Inc | 2013-06-04 | 44,034 | 0.02 | 661 |
| EVOK | Evoke Pharma Inc | 2016-05-26 | 861 | 0.44 | 376 |
| OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 5,064 | 0.01 | 27 |
Holding Weightings of Dp Vii Associates Lp
Dp Vii Associates Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Dp Vii Associates Lp has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the acquisition of 4,926 shares on November 29, 2010, which cost Dp Vii Associates Lp around $157,640.
According to the SEC Form 4 filings, Dp Vii Associates Lp has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 4,791 shares on July 1, 2013, which cost Dp Vii Associates Lp around $67,074.
According to the SEC Form 4 filings, Dp Vii Associates Lp has made a total of 0 transactions in Clovis Oncology Inc (CLVSQ) over the past 5 years. The most-recent trade in Clovis Oncology Inc is the sale of 2,779 shares on June 4, 2013, which brought Dp Vii Associates Lp around $179,468.
More details on Dp Vii Associates Lp's insider transactions can be found in the Insider Trading History of Dp Vii Associates Lp table.Insider Trading History of Dp Vii Associates Lp
- 1
Dp Vii Associates Lp Trading Performance
GuruFocus tracks the stock performance after each of Dp Vii Associates Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dp Vii Associates Lp is 12.2%. GuruFocus also compares Dp Vii Associates Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dp Vii Associates Lp within 3 months outperforms 3 times out of 17 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dp Vii Associates Lp's insider trading performs compared to the benchmark.
Performance of Dp Vii Associates Lp
Average Return
-5.98%
Outperforming Transactions
24%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.3 | 12.2 | -0.45 | -5.98 | -16.71 | -5.66 |
| Relative Return to S&P 500(%) | 10.2 | 6.69 | -8.29 | -17.89 | -28.19 | -17.49 |
Dp Vii Associates Lp Ownership Network
Ownership Network List of Dp Vii Associates Lp
Ownership Network Relation of Dp Vii Associates Lp
Dp Vii Associates Lp Owned Company Details
What does Regado Biosciences Inc do?
Who are the key executives at Regado Biosciences Inc?
Dp Vii Associates Lp is the 10 percent owner of Regado Biosciences Inc. Other key executives at Regado Biosciences Inc include 10 percent owner Domain Partners Vi, L.p. , Chief Medical Officer Eric Lefebvre , and Chief Financial Officer Christopher Peetz .
Regado Biosciences Inc (RGDO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Regado Biosciences Inc (RGDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regado Biosciences Inc (RGDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Regado Biosciences Inc (RGDO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regado Biosciences Inc Insider Transactions
Dp Vii Associates Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Dp Vii Associates Lp. You might contact Dp Vii Associates Lp via mailing address: One Palmer Sq, Ste 515, Princeton Nj 08542.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
